|
|
| | T5601640 Basic information |
| Product Name: | T5601640 | | Synonyms: | T5601640;T56-LIMKi;5-Isoxazolecarboxamide, 3-methyl-N-[3-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-;T56-LIMKi - T5601640;T5601640;T 5601640;T56-LIMKI;3-Methyl-N-[3-[[[3-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-5-isoxazolecarboxamide;T-5601640(T56-LIMKi);3-methyl-N-[3-[[3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-1,2-oxazole-5-carboxamide | | CAS: | 924473-59-6 | | MF: | C19H14F3N3O3 | | MW: | 389.33 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 924473-59-6.mol |  |
| | T5601640 Chemical Properties |
| Boiling point | 403.4±45.0 °C(Predicted) | | density | 1.426±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMF: 30 mg/ml; DMF:PBS(pH7.2) (1:2): 0.33 mg/ml; DMSO: 20 mg/ml | | pka | 11.41±0.70(Predicted) | | form | powder | | color | white to beige |
| RIDADR | UN 2811 6.1 / PGIII |
| | T5601640 Usage And Synthesis |
| Uses | T 5601640 is a LIMK inhibitor and is used for the treatment of proliferative disorders such as cancer, neurofibromatosis and neuronal differentiation associated disaeses. | | Biochem/physiol Actions | T56-LIMKi is a LIMK2 inhibitor that reduces phosphorylated cofilin, and induces disassembly of actin stress fibers in NF1-/- MEFs cells. | | storage | Store at +4°C |
| | T5601640 Preparation Products And Raw materials |
|